Citigroup Inc Mannkind Corp Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Mannkind Corp stock. As of the latest transaction made, Citigroup Inc holds 104,343 shares of MNKD stock, worth $654,230. This represents 0.0% of its overall portfolio holdings.

Number of Shares

104,343

Previous 653,406 84.03%

Holding current value

$654,230

Previous $2.96 Million 81.62%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$4.05 - $5.43 $2.22 Million - $2.98 Million	-549,063 Reduced 84.03%	104,343 $544,000
Q1 2024 May 10, 2024	BUY	$3.25 - $5.27 $981,581 - $1.59 Million	302,025 Added 85.95%	653,406 $2.96 Million
Q4 2023 Feb 09, 2024	SELL	$3.34 - $4.29 $39,174 - $50,317	-11,729 Reduced 3.23%	351,381 $1.28 Million
Q3 2023 Nov 09, 2023	SELL	$3.91 - $5.45 $184,325 - $256,923	-47,142 Reduced 11.49%	363,110 $1.5 Million
Q2 2023 Aug 10, 2023	SELL	$3.72 - $4.79 $2.6 Million - $3.35 Million	-698,334 Reduced 62.99%	410,252 $1.67 Million
Q1 2023 May 11, 2023	BUY	$3.95 - $5.63 $2.14 Million - $3.05 Million	542,155 Added 95.71%	1,108,586 $4.55 Million
Q4 2022 Feb 09, 2023	SELL	$3.02 - $5.37 $2.29 Million - $4.08 Million	-759,379 Reduced 57.28%	566,431 $2.99 Million
Q3 2022 Nov 10, 2022	BUY	$2.99 - $4.35 $2.68 Million - $3.9 Million	896,037 Added 208.49%	1,325,810 $4.1 Million
Q2 2022 Aug 10, 2022	BUY	$2.67 - $4.77 $738,783 - $1.32 Million	276,698 Added 180.76%	429,773 $1.64 Million
Q1 2022 May 12, 2022	SELL	$2.62 - $4.45 $1.36 Million - $2.31 Million	-518,140 Reduced 77.19%	153,075 $564,000
Q4 2021 Feb 10, 2022	BUY	$4.05 - $5.37 $1.28 Million - $1.69 Million	315,097 Added 88.48%	671,215 $2.93 Million
Q3 2021 Nov 10, 2021	BUY	$3.89 - $5.48 $1.39 Million - $1.95 Million	356,118 New	356,118 $1.55 Million

Others Institutions Holding MNKD

# of Institutions

219

Shares Held

133M

Call Options Held

1.43M

Put Options Held

851K

View Full List

About MANNKIND CORP

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.61B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

More about MNKD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account